Brain cancer propagating cells: biology, genetics and targeted therapies

  • Hadjipanayis C
  • Van Meir E
  • 78

    Readers

    Mendeley users who have this article in their library.
  • 83

    Citations

    Citations of this article.

Abstract

Cancer propagating cells (CPCs) within primary central nervous system (CNS) tumors (glioblastoma multiforme (GBM), medulloblastoma (MB) and ependymoma) might be integral to tumor development and perpetuation. These cells, also known as brain cancer propagating cells (BCPCs), have the ability to self-renew and proliferate. BCPCs can initiate new tumors in mice with high efficiency and these exhibit many features that are characteristic of patient's brain tumors. Accumulating evidence suggests that BCPCs might originate from the transformation of neural stem cells (NSCs) and their progenitors. Furthermore, recent studies have shown that NSC surface markers also define BCPCs. Ultimately, treatments that include specific targeting of BCPCs might potentially be more effective at treating the entire tumor mass, translating to improved patient survival and quality of life. © 2009 Elsevier Ltd. All rights reserved.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Costas G. Hadjipanayis

  • Erwin G. Van Meir

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free